Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...
Medical Device Network on MSN
BIOTRONIK begins trial of LivIQ pacemaker system
The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果